Opportunities arise from sustainability, advanced manufacturing, and digital procurement, driving performance-focused, aesthetic, and eco-friendly fiber cement board solutions across diverse ...
Commercial agreement potentially valued at approximately $4.5 million over five years following 18 month pilot; Service to be ...
Sarepta Therapeutics, Inc. , the leader in precision genetic medicine for rare diseases, today announced positive topline three-year functional results from Part 1-treated patients in EMBARK (Study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results